Publications related to outside publications | NDEWS l National Drug Early Warning System l University of Maryland

DEWS - Central Receiving Facility (CRF) at Gracepoint – Hillsborough County, FloridaWish, E.D., Billing, A.S., Artigiani, E.E, and Hippolyte, T. (2020). Office of National Drug Control Policy. Washington, DC: Executive Office of the President. CDEWS-5-Gracepoint-2020-FinalReport.pdf519.79 KB
Juvenile Assessment Center (JAC) Program - Tampa, FloridaWish, E.D., Billing, A.S., Artigiani, E.E, and Hippolyte, T. (2020). Office of National Drug Control Policy. Washington, DC: Executive Office of the President. CDEWS-5-TampaJAC-2020-FinalReport.pdf385.42 KB
Using Hospital Electronic Health Records to Monitor Drug Use Trends in Emergency Department Patients at the University of Maryland Prince George’s Hospital CenterBradford Schwartz, MD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA Cerner_Bulletin_May2019.pdf621.93 KB
Billing, A.S., Artigiani, E.E, Hippolyte, T., and Wish, E.D. (2019). Drug Early Warning Signals (DEWS): Serenity Lane - Coburg, Oregon. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Serenity-Lane-March-2019-Final.pdf1.06 MB
Billing, A.S., Artigiani, E.E., Hippolyte, T., and Wish, E.D. (2019). Drug Early Warning Signals (DEWS): Methodology Overview. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Methodology-Overview-March-2019.pdf1.37 MB
ToxIC Brief: Issue 3, Synthetic Cannabinoids Cases Reported to the ToxIC Registry, August 1, 2018–January 31, 2019 Meghan Spyres, MD; Paul Wax, MD; Sharan Campleman, PhD; Jeffrey Brent, MD, PhD; Diane Calello, MD American College of Medical Toxicology, Phoenix, AZ ToxIC-Series-Issue-3-FINAL.pdf302.33 KB
Wish, E.D., Billing, A.S., Artigiani, E.E, and Hippolyte, T. (2019). Drug Early Warning Signals (DEWS): Operation PAR – North Fort Myers, Florida. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Operation-PAR-March-2019-Final.pdf1.02 MB
Using Electronic Health Records to Track Emerging Drug Problems in Baltimore (February 2019)Zachary D.W. Dezman, MD, Daniel L. Lemkin, MD, J. Kathleen Tracy, PhD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA MPower_EpicBulletin_Feb2019_Revised.pdf443.65 KB
Novel Synthetic Opioids Cases Reported to the ToxIC Registry, August–October 2018 Meghan Spyres, MD; Paul Wax, MD; Sharan Campleman, PhD; Jeffrey Brent, MD, PhD; Diane Calello, MD American College of Medical Toxicology, Phoenix, AZ toxic-series-issue-2-final.pdf274.18 KB
Evaluation of Nicotine and the Components of e-Liquids Generated from e-Cigarette Aerosols Michelle R. Peace, Haley A. Mulder, Tyson R. Baird, Karen E. Butler, Alaina K. Friedrich, Joseph W. Stone, Joseph B. McGee Turner, Alphonse Poklis, Justin L. Poklis
The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids; Justin L. Poklis, Haley A. Mulder, Michelle R. Peace
Abbate, V., Schwenk, M., Presley, B.C., & Uchiyama, N. (2018). The ongoing challenge of novel psychoactive drugs of abuse: Part I. Synthetic cannabinoids (IUPAC Technical Report). Pure and Applied Chemistry, published online ahead of print.
Abrams, D.B., Glasser, A.M., Pearson, J.L., Villanti, A.C., Collins, L.K., & Niaura, R.S. (2018). Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives. Annual Review of Public Health, 39: 193-213.
Ahmad, F.B., Rossen, L.M., Spencer, M.R., Warner, M., & Sutton, P. (2018). Provisional drug overdose death counts. National Center for Health Statistics.
Buchanich, J.M., Balmert, L.C., Williams, K.E., & Burke, D.S. (2018). The Effect of Incomplete Death Certificates on Estimates of Unintentional Opioid-Related Overdose Deaths in the United States, 1999-2015. Public Health Reports, XX(X), 1-9.
Cramer, M. (2018). State’s highest court rules that judges may force defendants with drug addiction to stay sober. Boston Globe. Boston, Massachusetts.
Drug Enforcement Administration. (2018). Slang Terms and Code Words: A Reference for Law Enforcement Personnel. Intelligence Report. dea-drug-slang-terms-and-code-words-july2018.pdf1.35 MB
European Monitoring Centre for Drugs and Drug Addiction. (2018). 2018 European Drug Report.
European Monitoring Centre for Drugs and Drug Addiction. (2018). Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation — an update from the EU Early Warning System.
Florida Department of Law Enforcement. (2018). Drugs Identified in Deceased Persons by Florida Medical Examiners - 2017 Interim Report.
Governmnent Accountability Office. (2018). Illicit Opioids: Office of National Drug Control Policy and Other Agencies Need to Better Assess Strategic Efforts. Testimony Before the Committee on Oversight and Government Reform, House of Representatives.
Green, T.C., Clarke, J., & Brinkley-Rubinstein, L. (2018). Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System. JAMA Psychiatry, 75(4): 405-7.
Janakiram, C., Chalmers, N.I., Fontelo, P., Huser, V., Lopez-Mitnick, G., Iafolla, T.J., Brow, A.R., Dye, B.A. (2018). Sex and race or ethnicity disparities in opioid prescriptions for dental diagnoses among patients receiving Medicaid. Journal of the American Dental Association, 149(4): 246-55.
Jones C.M., Einstein E.B., & Compton W.M. (2018). Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016. JAMA., 319(17):1819–21.
Kann, L., McManus, T., Harris, W.A., et al. Youth Risk Behavior Surveillance — United States, 2017. MMWR Surveillance Summaries, 67(No. SS-8):1–114